| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |